In this manual :
1. WHAT IS PERCUTAFEINE, gel AND WHAT IS IT USED FOR?
2. WHAT DO YOU NEED TO KNOW BEFORE USING PERCUTAFEINE, gel?
3. HOW DO I USE PERCUTAFEINE, gel?
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
5. HOW TO USE PERCUTAFEINE, gel?
6. ADDITIONAL INFORMATION
1. WHAT IS PERCUTAFEINE, gel AND WHAT IS IT USED FOR?
Pharmacotherapeutic class
Not applicable.
Symptomatic treatment of localized subcutaneous fat deposits.
2. WHAT YOU SHOULD KNOW BEFORE USING PERCUTAFEINE, gel
List of information needed before taking the medicine
Not applicable.
Never use PERCUTAFEINE, gel in the following case:
- If you are allergic (hypersensitive) to caffeine or any of the other components contained in PERCUTAFEINE, gel.
IN CASE OF DOUBT, IT IS ESSENTIAL TO ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE
Precautions for use; special warnings
Be careful with PERCUTAFEINE, gel:
- do not apply to irritated or injured skin,
- because of the alcohol content of the gel, it should not be used in patients treated with disulfiram (ESPERAL),
- this treatment does not constitute in any way a basic treatment for obesity.
IF IN DOUBT, DO NOT HESITATE TO ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
Interactions with other medicines
Taking or using other medicines
IN ORDER TO AVOID POSSIBLE INTERACTIONS WITH OTHER MEDICINES, YOU SHOULD ALWAYS INFORM YOUR DOCTOR OR PHARMACIST OF ANY OTHER TREATMENT IN PROGRESS
Interactions with food and drink
Not applicable.
Interactions with herbal products or alternative therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy and lactation
This medicine should be used with caution during pregnancy and lactation. In the case of breastfeeding women, if applied to the breasts, clean the skin before each feed following application to the breasts.
In general, it is advisable to ask your doctor or pharmacist for advice before taking any medication.
Not applicable.
Effects on ability to drive or use machines
Not applicable.
List of excipients with a known effect
Not applicable.
3. HOW TO USE PERCUTAFEINE, gel
Instructions for proper use
Not applicable.
Dosage, Method and/or route(s) of administration, Frequency of administration and Duration of treatment
Dosage
Apply locally 10 to 20 g per day and massage in.
Symptoms and instructions in case of overdose
Not applicable.
Instructions in case of missed dose(s)
Not applicable.
Risk of withdrawal syndrome
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Description of side effects
Like all medicines, PERCUTAFEINE, gel is likely to have undesirable effects, although not everyone is subject to them.
Redness of the skin may appear, in which case it is advisable to stop treatment.
If you notice any side effects not mentioned in this leaflet, or if any side effects become serious, please tell your doctor or pharmacist.
5. HOW TO CONSERVE PERCUTAFEINE, gel?
Keep out of the reach and sight of children.
Do not use PERCUTAFEINE, gel after the expiry date stated on the outer packaging.
Do not refrigerate.
If necessary, warnings against certain visible signs of deterioration
Medicines should not be disposed of down the drain or in the household waste. Ask your pharmacist what to do with unused medicines. This will help to protect the environment.
6. ADDITIONAL INFORMATION
Complete list of active substances and excipients
What does PERCUTAFEINE gel contain?
The active substance is:
Caffeine ............................................................................................................................................ 5,000 g
Per 100 g of gel.
The other components are:
Carbomer (synthalene K), trolamine, cocoate of macrogol 7 glycerol (CETHIOL HE), 96 per cent ethanol, purified water.
Pharmaceutical form and content
What is PERCUTAFEINE gel and what does it contain?
This medicine is available as a gel in tubes of 20 g, 72 g, 80 g, 96 g, 144 g, 150 g, 192 g.
Name and address of the marketing authorisation holder and of the manufacturing authorisation holder responsible for batch release, if different
Holder
PIERRE FABRE MEDICAMENT
45, PLACE ABEL GANCE
92100 BOULOGNE BILLANCOURT
Operator
LABORATOIRES PIERRE FABRE MEDICAMENT
45, PLACE ABEL GANCE
92100 BOULOGNE
Manufacturer
Not known
Names of the medicinal product in the Member States of the European Economic Area
Not applicable.
Date of approval of the notice
The last date on which this leaflet was approved was {date}.
MA under exceptional circumstances
Not applicable.
Detailed information on this medicinal product is available on the website of Afssaps (France).
Information reserved for health professionals
Not applicable.
Not applicable.
Français
English
